Stockscreener 앱 받기
2.65
1.49%
-0.04
시간 외 거래:
2.65
전일 마감가:
$2.69
열려 있는:
$2.7
하루 거래량:
1.36M
Relative Volume:
0.78
시가총액:
$381.53M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-2.9428
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
+11.34%
1개월 성능:
+7.29%
6개월 성능:
-51.82%
1년 성능:
-71.07%
1일 변동 폭
$2.65
$2.825
1주일 범위
$2.385
$2.825
52주 변동 폭
$1.665
$10.03
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.65 | 387.29M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
Published on: 2025-07-28 23:24:21 - metal.it
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewswire
Maravai LifeSciences to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 11 - Quiver Quantitative
Should I hold or sell Maravai LifeSciences Holdings Inc. stock in 2025Breakthrough capital growth - jammulinksnews.com
Is Maravai LifeSciences Holdings Inc. a growth stock or a value stockDiscover high-impact stocks for growth - jammulinksnews.com
What are the technical indicators suggesting about Maravai LifeSciences Holdings Inc.Get real-time updates on market trends - jammulinksnews.com
Why is Maravai LifeSciences Holdings Inc. stock attracting strong analyst attentionUnlock powerful investment tools for free - jammulinksnews.com
How does Maravai LifeSciences Holdings Inc. compare to its industry peersCapitalize on strong market momentum - jammulinksnews.com
What is the dividend policy of Maravai LifeSciences Holdings Inc. stockDiscover top stock picks for aggressive growth - jammulinksnews.com
What is the risk reward ratio of investing in Maravai LifeSciences Holdings Inc. stockFree Capital Growth Strategies - jammulinksnews.com
Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attentionFree VIP Group - Newser
What drives Maravai LifeSciences Holdings Inc. stock pricePowerful market insights - PrintWeekIndia
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - Business Wire
What analysts say about Maravai LifeSciences Holdings Inc. stockGame-changing returns - PrintWeekIndia
Is Maravai LifeSciences Holdings Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia
Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - jammulinksnews.com
What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
16,587 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Teacher Retirement System of Texas - Defense World
Maravai LifeSciences appoints Deloitte as new auditor, replaces EY - Investing.com Australia
Maravai LifeSciences appoints Deloitte as new auditor, replaces EY By Investing.com - Investing.com India
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - MSN
Johnson Fistel, PLLP Continues Investigation Claims on Behalf of Quantum Computing Inc. (QUBT), AppLovin Corporation (APP), Skyworks Solutions, Inc. (SWKS), and Maravai LifeSciences Holdings, Inc. (MRVI) Long-Term Shareholders - GlobeNewswire
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):